The TILVANCE-301trial, expected to be completed in 2030, is the latest study of what has been described as one of the “phenomenal discoveries in melanoma.”
2023
TAFE Course Gives Hair And Beauty Students Techniques To Spot A Suspicious Skin Spot
TAFE NSW has partnered with the Australian Melanoma Research Foundation, Hair and Beauty Australia (HABA), Keune and Airyday to launch a new course to upskill hairdressers, barbers and beauticians with the techniques to recognise suspicious spots and how to speak up if they see spots that concern them.
Camrelizumab Plus Famitinib Demonstrates Early Antitumor Activity in Advanced Melanoma
Camrelizumab combined with famitinib elicited responses and was well tolerated in patients with advanced melanoma previously exposed to an immune checkpoint inhibitor regimen.
Hope Is Paramount During Uveal Melanoma Treatment
An expert gives an overview of the treatment options for uveal melanoma, and why he considers hope to be an essential part of the care plan.